MPS completed recently the commissioning of seven new Varian linear accelerators at the new state-of-the art facility for the Portuguese Institute of Oncology (IPO) in Porto, Portugal. In May 2011, MPS teamed up with Precess Medical Derivatives Inc. to provide expert support on the implementation of the new Varian Novalis stereotactic radiosurgery system.







